What is it about?
We analyzed 41 mechanically ventilated COVID-19 patients who underwent BAL analysis. Among them 29% developed HSV-1 reactivation. Eleven out of 12 patients with HSV-1 reactivation received antiviral therapy with intravenous acyclovir. HSV-1 reactivation is frequently detected in intubated patients with COVID-19.
Featured Image
Photo by CDC on Unsplash
Why is it important?
This paper provides initial evidence on the prevalence of HSV-1 reactivation in COVID-19 mechanically ventilated patients.
Read the Original
This page is a summary of: Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers, Microorganisms, February 2022, MDPI AG,
DOI: 10.3390/microorganisms10020362.
You can read the full text:
Contributors
The following have contributed to this page
